The Effect of Docosahexaenoic Acid on Serum Levels of Apolipoproteins in Patients with Type-2 Diabetes Mellitus: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

MIR MOHAMMAD SADEGHI M.; MOHAMMADZADEH HONARVAR N.; QORBANI M.; MANSOORI A.; KOOHDANI F.

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: JOURNAL OF SCHOOL OF PUBLIC HEALTH AND INSTITUTE OF PUBLIC HEALTH RESEARCH Year:2018 | Volume:16 | Issue:2 Page(s): 180-195

Download Full-Text

Persian Verion

View:

370

Download:

Cites:

Information Journal Paper

Title

The Effect of Docosahexaenoic Acid on Serum Levels of Apolipoproteins in Patients with Type-2 Diabetes Mellitus: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial

Author(s)

Keywords

Docosahexaenoic AcidQ1

Apolipoprotein A1Q1

Apolipoprotein A2Q1

Apolipoprotein B48Q1

Apolipoprotein C3Q1

Type-2 DiabetesQ1

Abstract

Background and Aim: Lipoprotein disorders are an integral component of Type-2 Diabetes mellitus (T2DM). Therefore, early diagnosis and treatment of lipid disorders can be beneficial in prevention and treatment of many complications associated with T2DM. The aim of this study wasto determine the effect of Docosahexaenoic Acid (DHA) supplementation on the serum levels of apolipoproteins (Apos) A1, A2, B48 and C3 in patients withT2DM. Materials and Methods: In this 8-week randomized, double-blind, placebo-controlled clinical trial, 44 T2DMpatients were randomly assigned to either an experimental group (n=22, receiving daily 2. 4 g DHA) or a placebo group (n = 22, receiving paraffin). The serum levels of AposA1, A2, B48 and C3 were measured in all the patients at the beginning and at the end of the period. Results: There was a statistically significant increase in the mean serum level of ApoA1 in the DHA group (p = 0. 014). In addition, a significant difference was observed in the serum level of ApoC3 after intervention between the DHA and placebo group (p=0. 031). There were no significant differences between the two groups as regards the mean changes in serum levels of ApoA1, ApoA2, ApoB48 and ApoC3. Conclusions: Dietary supplementation with Docosahexaenoic Acidhasno effects on the serum levels of apolipoproteins in patients with Type-2 Diabetes.

Cites

No record.

References

No record.

Cite

APA: Copy

MIR MOHAMMAD SADEGHI, M., MOHAMMADZADEH HONARVAR, N., QORBANI, M., & MANSOORI, A.. (2018). The Effect of Docosahexaenoic Acid on Serum Levels of Apolipoproteins in Patients with Type-2 Diabetes Mellitus: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial. JOURNAL OF SCHOOL OF PUBLIC HEALTH AND INSTITUTE OF PUBLIC HEALTH RESEARCH, 16(2 ), 180-195. SID. https://sid.ir/paper/84915/en

Vancouver: Copy

MIR MOHAMMAD SADEGHI M., MOHAMMADZADEH HONARVAR N., QORBANI M., MANSOORI A.. The Effect of Docosahexaenoic Acid on Serum Levels of Apolipoproteins in Patients with Type-2 Diabetes Mellitus: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial. JOURNAL OF SCHOOL OF PUBLIC HEALTH AND INSTITUTE OF PUBLIC HEALTH RESEARCH[Internet]. 2018;16(2 ):180-195. Available from: https://sid.ir/paper/84915/en

IEEE: Copy

M. MIR MOHAMMAD SADEGHI, N. MOHAMMADZADEH HONARVAR, M. QORBANI, and A. MANSOORI, “The Effect of Docosahexaenoic Acid on Serum Levels of Apolipoproteins in Patients with Type-2 Diabetes Mellitus: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial,” JOURNAL OF SCHOOL OF PUBLIC HEALTH AND INSTITUTE OF PUBLIC HEALTH RESEARCH, vol. 16, no. 2 , pp. 180–195, 2018, [Online]. Available: https://sid.ir/paper/84915/en

Related Journal Papers